Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Clinical trials

Showing 12 out of 308 results
The DETERMINE trial team celebrating at the Bionow awards

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

by Tim Bodicoat | In depth | 28 February 2025

28 February 2025

A green beam of light from a radiotherapy machine.

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

by Tim Gunn | In depth | 17 February 2025

17 February 2025

The capsule sponge shown in pill form and sponge form. Both are black and attached to a white thread.

Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme. Our BEST4 Screening trial will give 120,000 people with chronic heartburn a 'pill-on-a-thread' test to look for signs of Barrett's oesophagus, a rare condition that can lead to oesophageal cancer. The results will show whether the UK can use the test for a new oesophageal cancer screening programme.

by Tim Gunn | Analysis | 28 November 2024

28 November 2024

A magnified image of squamous cell carcinoma, the most common type of cervical cancer.

Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs.  Researchers funded by Cancer Research UK have made the biggest improvement in cervical cancer treatment in more than 20 years by changing how we use existing drugs. 

by Sophie Wedekind | 14 October 2024

14 October 2024

Caitlin, who was diagnosed with Ewing sarcoma this year and is going to take part in our INTER-EWING-1 trial.

INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.   INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.  

by Momoko Bowles | Analysis | 25 September 2024

25 September 2024

Abdullah, Aleesha-Marie and Faye, who all took part in clinical trials funded by Cancer Research UK

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

by Tom Bourton, Tim Gunn | Personal stories | 3 September 2024

3 September 2024

A microscope image showing cells affected by Barrett's oesophagus, a precancer that can lead to oesophageal cancer.

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

by Amy Warnock | Analysis | 9 February 2024

9 February 2024

A Cancer Research UK-funded researcher in the lab.

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

by Tim Gunn | News | 10 January 2024

10 January 2024

Two researchers smiling as they work together in a lab

2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023. 2023 has been a big year for Cancer Research UK, and there's been a lot to celebrate. So, to end the year, we want to highlight just a few of our most exciting research stories of 2023.

by Jacob Smith | In depth | 18 December 2023

18 December 2023

Antibody

Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug... Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug...

by Cancer Research UK | In depth | 12 December 2023

12 December 2023

That Cancer Conversation in a white speech bubble with a dark blue background

In this episode of That Cancer Conversation, we're going to take you into the world of clinical research and walk you through the pathway to give you the full picture of what a clinical trial really involves.  In this episode of That Cancer Conversation, we're going to take you into the world of clinical research and walk you through the pathway to give you the full picture of what a clinical trial really involves. 

by Cancer Research UK | Podcast | 27 November 2023

27 November 2023

This entry is part 12 of 25 in the series That Cancer Conversation